These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

550 related items for PubMed ID: 27017949

  • 21. Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progression.
    Debiais-Delpech C, Godet J, Pedretti N, Bernard FX, Irani J, Cathelineau X, Cussenot O, Fromont G.
    Urol Oncol; 2014 May; 32(4):426-32. PubMed ID: 24332637
    [Abstract] [Full Text] [Related]

  • 22. Clinical significance of proliferative inflammatory atrophy finding in prostatic biopsies.
    Servian P, Celma A, Planas J, Placer J, de Torres IM, Olivan M, Morote J.
    Prostate; 2015 Oct; 75(14):1669-75. PubMed ID: 26184870
    [Abstract] [Full Text] [Related]

  • 23. Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions.
    Henrique R, Jerónimo C, Hoque MO, Carvalho AL, Oliveira J, Teixeira MR, Lopes C, Sidransky D.
    DNA Cell Biol; 2005 Apr; 24(4):264-9. PubMed ID: 15812243
    [Abstract] [Full Text] [Related]

  • 24. Loss of miR-449a-caused PrLZ overexpression promotes prostate cancer metastasis.
    Chen W, Liu Y, Chen H, Ning H, Ding K.
    Int J Oncol; 2017 Aug; 51(2):435-444. PubMed ID: 28627667
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues: implications for prostate carcinogenesis and progression of prostate cancer.
    Zhigang Z, Wenlv S.
    Jpn J Clin Oncol; 2004 Jul; 34(7):414-9. PubMed ID: 15342669
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Positive predictive value of high-grade prostatic intraepithelial neoplasia in initial core needle biopsies of prostate adenocarcinoma--a study with complete sampling of hemi-prostates with corresponding negative biopsy findings.
    Delatour NL, Mai KT.
    Urology; 2008 Sep; 72(3):623-7. PubMed ID: 18279923
    [Abstract] [Full Text] [Related]

  • 32. Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells.
    Jones DZ, Schmidt ML, Suman S, Hobbing KR, Barve SS, Gobejishvili L, Brock G, Klinge CM, Rai SN, Park J, Clark GJ, Agarwal R, Kidd LR.
    BMC Cancer; 2018 Apr 13; 18(1):421. PubMed ID: 29653561
    [Abstract] [Full Text] [Related]

  • 33. Flutamide reduced prostate cancer development and prostate stem cell antigen mRNA expression in high grade prostatic intraepithelial neoplasia.
    Zhigang Z, Wenlu S.
    Int J Cancer; 2008 Feb 15; 122(4):864-70. PubMed ID: 17957793
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. TMPRSS2:ERG gene fusion predicts subsequent detection of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia.
    Park K, Dalton JT, Narayanan R, Barbieri CE, Hancock ML, Bostwick DG, Steiner MS, Rubin MA.
    J Clin Oncol; 2014 Jan 20; 32(3):206-11. PubMed ID: 24297949
    [Abstract] [Full Text] [Related]

  • 36. High grade prostatic intraepithelial neoplasia does not display loss of heterozygosity at the mutation locus in BRCA2 mutation carriers with aggressive prostate cancer.
    Willems-Jones A, Kavanagh L, Clouston D, Bolton D, kConFab Investigators, Fox S, Thorne H.
    BJU Int; 2012 Dec 20; 110(11 Pt C):E1181-6. PubMed ID: 23035815
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Clinicopathological analysis of intraductal proliferative lesions of prostate: intraductal carcinoma of prostate, high-grade prostatic intraepithelial neoplasia, and atypical cribriform lesion.
    Miyai K, Divatia MK, Shen SS, Miles BJ, Ayala AG, Ro JY.
    Hum Pathol; 2014 Aug 20; 45(8):1572-81. PubMed ID: 24842280
    [Abstract] [Full Text] [Related]

  • 39. PrLZ regulates EMT and invasion in prostate cancer via the TGF-β1/p-smad2/miR-200 family/ZEB1 axis.
    Xie H, Chen J, Ma Z, Gao Y, Zeng J, Chen Y, Yang Z, Xu S.
    Prostate; 2024 Mar 20; 84(4):317-328. PubMed ID: 38145367
    [Abstract] [Full Text] [Related]

  • 40. Altered miRNA expression in high-fat diet-induced prostate cancer progression.
    Nara T, Narita S, Mingguo H, Yoshioka T, Koizumi A, Numakura K, Tsuruta H, Maeno A, Saito M, Inoue T, Tsuchiya N, Satoh S, Habuchi T.
    Carcinogenesis; 2016 Dec 20; 37(12):1129-1137. PubMed ID: 27915273
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.